Postoperative excessive gain in visceral adipose tissue as well as body mass index are associated with adverse outcomes of an ileal pouch.
There are no published studies on the impact of visceral adipose tissue (VAT) change on outcomes of restorative proctocolectomy and ileal pouch-anal anastomosis (IPAA). The aim of this historic cohort study was to evaluate the impact of excessive VAT gain on the outcomes of inflammatory bowel disease (IBD) patients with IPAA.



We evaluated all eligible patients with at least two sequential CT scans after pouch construction from our prospectively maintained Pouchitis Registry between 2002 and 2014. The visceral fat area (VFA) was measured on CT images. The study group comprised patients with a significant VAT gain (> 15%), and the control group was those without. The adverse outcomes of the pouch were defined as the new development of chronic pouch inflammation (chronic pouchitis, chronic cuffitis or Crohn's disease of the pouch), anastomotic sinus and the combination of above (the composite adverse outcome) or pouch failure, after the inception CT.



Of 1564 patients in the Registry, 59 (3.8%) with at least 2 CT scans after pouch surgery were included. Twenty-nine patients (49.2%) were in the study group, and 30 (50.8%) were in the control group. The median duration from the inception to the latest CT was 552 (range: 31-2598) days for the entire cohort. We compared the frequency of new chronic pouch inflammation (13.8% vs 3.3%, P = 0.195), new pouch sinus (10.3% vs 0%, P = 0.112), composite adverse pouch outcome (24.1% vs 3.3%, P = 0.026) or pouch failure (10.3% vs 6.7%, P = 0.671) between the two groups. Kaplan-Meier plot for time-to-pouch failure between the pouch patients with or without excessive body mass index (BMI) gain (> 10%) showed statistical difference (P = 0.011). Limited stepwise multivariate analysis showed that excessive VAT gain (odds ratio = 12.608, 95% confidence interval: 1.190-133.538, P = 0.035) was an independent risk factor for the adverse pouch comes.



In this cohort of ileal pouch patients, excessive VAT gain as well as gain in BMI after pouch construction was found to be associated with poor long-term outcomes.
Department of Colorectal Surgery, the Cleveland Clinic Foundation, Cleveland, OH, USA Department of Geriatric Surgery, the Second Xiangya Hospital, Central South University, Changsha, China.
Ganglei
G
Liu
Department of Colorectal Surgery, the Cleveland Clinic Foundation, Cleveland, OH, USA.
Xianrui
X
Wu
Department of Colorectal Surgery, the Cleveland Clinic Foundation, Cleveland, OH, USA.
Yi
Y
Li
Department of Colorectal Surgery, the Cleveland Clinic Foundation, Cleveland, OH, USA.
Yuanyi
Y
Rui
Department of Colorectal Surgery, the Cleveland Clinic Foundation, Cleveland, OH, USA.
Luca
L
Stocchi
Department of Colorectal Surgery, the Cleveland Clinic Foundation, Cleveland, OH, USA.
Feza H
FH
Remzi
Department of Colorectal Surgery, the Cleveland Clinic Foundation, Cleveland, OH, USA Department of Gastroenterology/Hepatology, the Cleveland Clinic Foundation, Cleveland, OH, USA shenb@ccf.org.
Bo
B
Shen
 inflammatory bowel disease; ileal pouch; pouch failure; visceral adipose tissue; visceral fat area
Minerva Gastroenterol Dietol. 2012 Jun;58(2):123-35
22643595
Eur J Surg Oncol. 2015 Feb;41(2):186-96
25468746
Inflamm Bowel Dis. 2012 Aug;18(8):1550-7
22407798
Inflamm Bowel Dis. 2013 Sep;19(10):2173-81
23899541
PLoS One. 2013 Oct 24;8(10):e78495
24205244
Soc Work Health Care. 1991;15(4):19-30
1957239
Colorectal Dis. 2015 Mar;17(3):225-34
25307174
Annu Rev Immunol. 2011;29:415-45
21219177
Physiol Rev. 2000 Apr;80(2):649-80
10747204
J Gastrointest Surg. 2008 Oct;12(10):1738-44
18709420
Am J Gastroenterol. 2006 Dec;101(12):2760-8
17227523
Mol Nutr Food Res. 2015 Jan;59(1):75-93
25418549
Br J Surg. 1992 Sep;79(9):955-8
1422768
Gut. 2007 Apr;56(4):577-83
16956921
Clin Colon Rectal Surg. 2010 Dec;23(4):259-68
22131896
Aliment Pharmacol Ther. 2009 Mar 1;29(5):519-26
19183338
Clin Gastroenterol Hepatol. 2006 Jan;4(1):81-9; quiz 2-3
16431309
World J Gastroenterol. 2014 May 14;20(18):5177-90
24833848
Gut. 2010 Mar;59(3):341-7
19837679
Digestion. 2013;88(1):26-32
23816835
J Gastrointest Surg. 2014 Mar;18(3):573-9
24091910
Am J Clin Nutr. 2002 Apr;75(4):683-8
11916754
Inflamm Bowel Dis. 2013 Feb;19(2):404-10
23328773
Ann Oncol. 2015 Jun;26(6):1101-1109
25480876
Br J Nutr. 2010 Aug;104(4):582-8
20370942
Diabetol Metab Syndr. 2011 Jun 22;3:12
21696633
Int J Obes (Lond). 2007 May;31(5):763-9
17060927
Dis Colon Rectum. 2011 Dec;54(12):1488-95
22067176
Clin Nutr. 2002 Feb;21(1):51-7
11884013
Clin Gastroenterol Hepatol. 2006 Apr;4(4):482-8
16616354
Physiol Behav. 2012 Aug 20;107(1):154-71
22548766
Surg Endosc. 2013 Nov;27(11):4325-32
23877758
Front Immunol. 2014 Sep 24;5:462
25309544
Am J Clin Nutr. 2007 Feb;85(2):362-8
17284730
Br J Radiol. 2009 Feb;82(974):123-30
19168691
Horm Mol Biol Clin Investig. 2014 Jul;19(1):57-74
25390016
Am J Gastroenterol. 2002 Apr;97(4):972-7
12003434
J Gastroenterol Hepatol. 2008 Mar;23(3):411-7
17725596